- Home
- TVRD vs CIO Comparison
TVRD vs CIO Comparison
Compare TVRD & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- CIO
- Stock Information
- Founded
- TVRD 2017
- CIO 2013
- Country
- TVRD United States
- CIO Canada
- Employees
- TVRD N/A
- CIO N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- CIO Real Estate Investment Trusts
- Sector
- TVRD Health Care
- CIO Real Estate
- Exchange
- TVRD Nasdaq
- CIO Nasdaq
- Market Cap
- TVRD 246.5M
- CIO 215.5M
- IPO Year
- TVRD N/A
- CIO 2014
- Fundamental
- Price
- TVRD $29.44
- CIO $5.82
- Analyst Decision
- TVRD Strong Buy
- CIO
- Analyst Count
- TVRD 5
- CIO 0
- Target Price
- TVRD $59.20
- CIO N/A
- AVG Volume (30 Days)
- TVRD 93.5K
- CIO 132.1K
- Earning Date
- TVRD 08-21-2025
- CIO 07-31-2025
- Dividend Yield
- TVRD N/A
- CIO 6.92%
- EPS Growth
- TVRD N/A
- CIO N/A
- EPS
- TVRD N/A
- CIO N/A
- Revenue
- TVRD N/A
- CIO $168,891,000.00
- Revenue This Year
- TVRD N/A
- CIO $1.13
- Revenue Next Year
- TVRD N/A
- CIO $3.73
- P/E Ratio
- TVRD N/A
- CIO N/A
- Revenue Growth
- TVRD N/A
- CIO N/A
- 52 Week Low
- TVRD $8.13
- CIO $4.19
- 52 Week High
- TVRD $34.31
- CIO $6.50
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- CIO 70.03
- Support Level
- TVRD N/A
- CIO $5.42
- Resistance Level
- TVRD N/A
- CIO $5.65
- Average True Range (ATR)
- TVRD 0.00
- CIO 0.17
- MACD
- TVRD 0.00
- CIO 0.01
- Stochastic Oscillator
- TVRD 0.00
- CIO 98.18
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.